The Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences is consistently developing its expertise in the field of innovative, personalised therapies, basing this not only on scientific excellence but also on building partnerships with experts and leaders in the biotechnology sector.

A visit to SyVento BioTech, a company that combines research and development (R&D) with GMP-compliant manufacturing, represents a further step in strengthening our expertise in the development and manufacture of products for early-phase clinical trials.

We believe that the combination of both partners’ knowledge, experience and modern infrastructure will contribute to the faster implementation of modern, personalised therapies into clinical practice.